Mycobacterium colombiense Pneumonia in HIV-Infected Patients: Three Case Reports and a Literature Review

References

• Kobayashi T, Nishijima T, Teruya K, et al. High mortality of disseminated non-tuberculous mycobacterial infection in HIV-infected patients in the antiretroviral therapy era. PLoS One. 2016;11(3):e0151682. doi:10.1371/journal.pone.0151682
   PubMed Web of Science ®Google Scholar
• Bjerrum S, Oliver-Commey J, Kenu E, et al. Tuberculosis and non-tuberculous mycobacteria among HIV-infected individuals in Ghana. Trop Med Int Health. 2016;21(9):1181–1190. doi:10.1111/tmi.12749
   PubMed Web of Science ®Google Scholar
• World Health Organization. The top 10 causes of death. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed September 16, 2020.
   Google Scholar
• Griffiths EC, Pedersen AB, Fenton A, Petchey OL. The nature and consequences of coinfection in humans. J Infect. 2011;63(3):200–206. doi:10.1016/j.jinf.2011.06.005
   PubMed Web of Science ®Google Scholar
• Subahi EA, Aljafar MS, Barjas HH, Abdelrazek M, Rasoul FA. Co-infection by Cryptococcus neoformans fungaemia and non-tuberculous mycobacteria with Pneumocystis jiroveci pneumonia in a newly diagnosed HIV-infected patient. Clin Case Rep. 2021;9(7):e04191. doi:10.1099/jmm.0.000994
   PubMed Web of Science ®Google Scholar
• Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the centers for disease control and prevention. The National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed August, 2021.
   Google Scholar
• Wang J, Han Y, Feng J. Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis. BMC Pulm Med. 2019;19(1):252. doi:10.1186/s12890-019-1022-4
   PubMed Web of Science ®Google Scholar
• Deurenberg RH, Bathoorn E, Chlebowicz MA, et al. Application of next generation sequencing in clinical microbiology and infection prevention. J Biotechnol. 2017;243:16–24. doi:10.1016/j.jbiotec.2016.12.022
   PubMed Web of Science ®Google Scholar
• Simner PJ, Miller S, Carroll KC. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. Clin Infect Dis. 2018;66(5):778–788. doi:10.1093/cid/cix881
   PubMed Web of Science ®Google Scholar
• Ramachandran PS, Cresswell FV, Meya DB, et al. Detection of Cryptococcus DNA by metagenomic next-generation sequencing in symptomatic cryptococcal antigenemia. Clin Infect Dis. 2019;68(11):1978–1979. doi:10.1093/cid/ciy1024
   PubMed Web of Science ®Google Scholar
• Xing XW, Zhang JT, Ma YB, Zheng N, Yang F, Yu SY. Apparent performance of metagenomic next-generation sequencing in the diagnosis of cryptococcal meningitis: a descriptive study. J Med Microbiol. 2019;68(8):1204–1210. doi:10.1099/jmm.0.000994
   PubMed Web of Science ®Google Scholar
• Zhou H, Larkin PMK, Zhao D, et al. Clinical impact of metagenomic next-generation sequencing of bronchoalveolar lavage in the diagnosis and management of pneumonia: a multicenter prospective observational study. J Mol Diagn. 2021;23(10):1259–1268. doi:10.1016/j.jmoldx.2021.06.007
   PubMed Web of Science ®Google Scholar
• Xie Y, Dai B, Zhou X, et al. Diagnostic value of metagenomic next-generation sequencing for multi-pathogenic pneumonia in HIV-infected patients. Infect Drug Resist. 2023;16:607–618. doi:10.2147/IDR.S394265
   PubMed Web of Science ®Google Scholar
• Lee MR, Chien JY, Huang YT, et al. Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008–2014. Int J Antimicrob Agents. 2017;50(1):35–40. doi:10.1016/j.ijantimicag.2017.02.016
   PubMed Web of Science ®Google Scholar
• Yu X, Jiang W. Mycobacterium colombiense and Mycobacterium avium complex causing severe pneumonia in a patient with HIV identified by a novel molecular-based method. Infect Drug Resist. 2021;14:11–16. doi:10.2147/IDR.S282190
   PubMed Web of Science ®Google Scholar
• Murcia MI, Tortoli E, Menendez MC, Palenque E, Garcia MJ. Mycobacterium colombiense sp. nov., a novel member of the Mycobacterium avium complex and description of MAC-X as a new ITS genetic variant. Int J Syst Evol Microbiol. 2006;56(Pt 9):2049–2054. doi:10.1099/ijs.0.64190-0
   PubMedGoogle Scholar
• Gonzalez-Perez M, Murcia MI, Landsman D, Jordan IK, Marino-Ramirez L. Genome sequence of the Mycobacterium colombiense type strain, CECT 3035. J Bacteriol. 2011;193(20):5866–5867. doi:10.1128/JB.05928-11
   PubMed Web of Science ®Google Scholar
• Pena E, Machado D, Viveiros M, Jordao S. A case report of disseminated Mycobacterium colombiense infection in an HIV patient. Int J Mycobacteriol. 2019;8(3):295–297. doi:10.4103/ijmy.ijmy_100_19
   PubMed Web of Science ®Google Scholar
• Leguizamon J, Hernandez J, Murcia MI, Soto CY. Identification of potential biomarkers to distinguish Mycobacterium colombiense from other mycobacterial species. Mol Cell Probes. 2013;27(1):46–52. doi:10.1016/j.mcp.2012.08.009
   PubMed Web of Science ®Google Scholar
• Maurer FP, Pohle P, Kernbach M, et al. Differential drug susceptibility patterns of Mycobacterium chimaera and other members of the Mycobacterium avium-intracellulare complex. Clin Microbiol Infect. 2019;25(3):379 e1–379 e7. doi:10.1016/j.cmi.2018.06.010
   PubMed Web of Science ®Google Scholar
• Gordin FM, Sullam PM, Shafran SD, et al. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex. Clin Infect Dis. 1999;28(5):1080–1085. doi:10.1086/514748
   PubMed Web of Science ®Google Scholar
• Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. doi:10.1164/rccm.200604-571ST
   PubMed Web of Science ®Google Scholar
• Chen LC, Huang HN, Yu CJ, Chien JY, Hsueh PR. Clinical features and treatment outcomes of Mycobacterium chimaera lung disease and antimicrobial susceptibility of the mycobacterial isolates. J Infect. 2020;80(4):437–443. doi:10.1016/j.jinf.2020.01.005
   PubMed Web of Science ®Google Scholar
• Schulthess B, Schafle D, Kalin N, Widmer T, Sander P. Drug susceptibility distributions of Mycobacterium chimaera and other non-tuberculous mycobacteria. Antimicrob Agents Chemother. 2023;65(5). doi:10.1128/AAC.02131-20
   PubMed Web of Science ®Google Scholar
• Liu CF, Song YM, He WC, et al. Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey. Infect Dis Poverty. 2021;10(1):59. doi:10.1186/s40249-021-00844-1
   PubMed Web of Science ®Google Scholar
• Van Boheemen S, van Rijn AL, Pappas N, et al. Retrospective validation of a metagenomic sequencing protocol for combined detection of RNA and DNA viruses using respiratory samples from pediatric patients. J Mol Diagn. 2020;22(2):196–207. doi:10.1016/j.jmoldx.2019.10.007
   PubMed Web of Science ®Google Scholar
• Schlaberg R, Chiu CY, Miller S, et al. Validation of metagenomic next-generation sequencing tests for universal pathogen detection. Arch Pathol Lab Med. 2017;141(6):776–786. doi:10.5858/arpa.2016-0539-RA
   PubMed Web of Science ®Google Scholar
• Blauwkamp TA, Thair S, Rosen MJ, et al. Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease. Nat Microbiol. 2019;4(4):663–674. doi:10.1038/s41564-018-0349-6
   PubMed Web of Science ®Google Scholar